Home / Tag Archives: incyte

Tag Archives: incyte

September, 2018

July, 2018

June, 2018

April, 2018

January, 2018

October, 2017

June, 2017

April, 2017

March, 2017

  • 31 March

    Incyte, Merck Provide Details on Collaboration of Epacadostat and Keytruda

    WILMINGTON, Del. & KENILWORTH, N.J.–(BUSINESS WIRE)–Incyte Corporation (Nasdaq:INCY) and Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced additional details of their clinical development program investigating the combination of epacadostat, Incyte’s investigational oral selective IDO1 enzyme inhibitor, with KEYTRUDA®(pembrolizumab), Merck’s anti-PD-1 therapy, in patients across five …